Ok. Ive had a little read over the announcements. Here is my summary.
> Purchase Price of €15.4m + earn out (ended up being €4.322m).
> to be paid 50% in cash up-front (€7.7m) and the balance (€7.7m) to be paid via a deferred payment plan of Eight (8) instalments, each equal to €962,500
> Earn out was to be paid Jan 11th. Was deferred to July 11th. As part of the vendor agreeing to the defereal, they reduced the amount of the earn-out that could be paid via equity from 20% to 15% and now to 5% (as in diasource wanted cash not ADO shares). the earn out was for 2015 and 2016. Was the earn-out at the floor price of 15c? if so, Anteo are giving up a lot just to survive.
> Now the earnout payment also attracts 8% interest (ie, more cashflow pressure). Has to be paid by October.
I also trawled the Annual Report and cant really see what diasource contributed to the bottom line. It looks to me that if Diasource is making a profit then all of it and more is being sucked up in Anteo expenses. Last cashflow report shows that even if ADO didnt have the ~€962k repayments the business would only be wiping its face (ie, no free cashflow). I would love to know more details about the earn out as it seems very high.
With more repayments due, cashflow would be getting awefully tight and i wonder how close they are to calling in administrators (cash at end of qrt was €1066k and they had €962k to pay back). If I were ADO, id either try and sell some of the MnG business pronto. or i'd totally stop unnecessary expenditure. When I mean unnecessary, I mean any expenses that don't contribute immediate to cashflow (more than the expense).
They have to pay back €4.322 (with only 5% being able to be repaid with equity) and another installment payment by Oct 2017. So as I see it, they effectively need to raise ~€5.0m by Oct with ~€200k to be paid in equity.
- Forums
- ASX - By Stock
- ADO
- Ann: Revised Payment Arrangements with DIAsource Vendors
Ann: Revised Payment Arrangements with DIAsource Vendors, page-148
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $54.30M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $12.91K | 587.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 371473 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 289608 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 371473 | 0.021 |
13 | 2204550 | 0.020 |
8 | 2890767 | 0.019 |
10 | 1652665 | 0.018 |
3 | 94160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 289608 | 2 |
0.023 | 864053 | 6 |
0.024 | 1306228 | 3 |
0.025 | 214144 | 4 |
0.027 | 680612 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online